Vistin Pharma ASA (LON:0RAM)
London flag London · Delayed Price · Currency is GBP · Price in NOK
22.90
-1.50 (-6.15%)
At close: Jan 15, 2025

Vistin Pharma ASA Cash Flow Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
62.7545.6-4.7224.87-96.96
Upgrade
Depreciation & Amortization
19.0317.3512.2810.619.62
Upgrade
Other Operating Activities
17.712.92-1.297.13-27.31
Upgrade
Change in Accounts Receivable
-12.14-20.81-12.762.16
Upgrade
Change in Inventory
-3.28-40.54-11.12-7.68
Upgrade
Change in Other Net Operating Assets
5.5-0.6944.57-5.05-25.56
Upgrade
Operating Cash Flow
104.9890.59-10.5113.68-145.73
Upgrade
Operating Cash Flow Growth
15.88%----
Upgrade
Capital Expenditures
-40.8-17.9-64.29-31.94-53.1
Upgrade
Other Investing Activities
-0.220.030.271.73
Upgrade
Investing Cash Flow
-40.8-17.68-64.26-31.68-51.38
Upgrade
Short-Term Debt Issued
--45.14--
Upgrade
Total Debt Issued
--45.14--
Upgrade
Short-Term Debt Repaid
--45.14---
Upgrade
Long-Term Debt Repaid
--0.9-2.59-0.84-0.43
Upgrade
Total Debt Repaid
--46.05-2.59-0.84-0.43
Upgrade
Net Debt Issued (Repaid)
--46.0542.55-0.84-0.43
Upgrade
Common Dividends Paid
-77.59---22.17-44.35
Upgrade
Other Financing Activities
--2.1-2.09-0.29-0.75
Upgrade
Financing Cash Flow
-77.59-48.1440.46-23.3-45.53
Upgrade
Miscellaneous Cash Flow Adjustments
-0000-0
Upgrade
Net Cash Flow
-13.4124.77-34.31-41.29-242.64
Upgrade
Free Cash Flow
64.1872.69-74.8-18.26-198.83
Upgrade
Free Cash Flow Growth
-11.71%----
Upgrade
Free Cash Flow Margin
14.94%16.58%-24.54%-6.55%-78.31%
Upgrade
Free Cash Flow Per Share
1.451.64-1.69-0.41-4.48
Upgrade
Cash Interest Paid
-2.12.090.290.75
Upgrade
Levered Free Cash Flow
32.9453.19-81.62-30.41-44.79
Upgrade
Unlevered Free Cash Flow
41.8554.6-80.28-30.19-44.28
Upgrade
Change in Net Working Capital
-10.31-12.2924.4629.6429.27
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.